Low-dose leucovorin and 5-fluorouracil for unresectable multiple liver metastasis from colorectal cancer

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4747-4752

  Ishibashi, Keiichiro ^a   Yoshimatsu, Kazuhiko ^a   Yokomizo, Hajime ^a   Umehara, Arihiro ^a   Yoshida, Kiyohito ^a   Fujimoto, Takashi ^a   Watanabe, Kiyo ^a   Katsube, Takao ^a   Naritaka, Yoshihiko ^a   Ogawa, Kenji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

5 Fluorouracil; Colorectal cancer; Leucovorin; Liver metastasis

Indexed keywords

CISPLATIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DIARRHEA; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG ADMINISTRATION ROUTE; FEMALE; HUMAN; LEUKOPENIA; LIVER METASTASIS; LOW DRUG DOSE; MALE; NAUSEA; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; STOMATITIS; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 28444446239     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. The Advanced Colorectal Cancer Meta-analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903, 1992.
2. Davis HL: Chemotherapy of large bowel cancer. Cancer 50: 2638-2646, 1982.
3. O'Connell MJ: A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. Cancer 63: 1026-1030, 1989.
4. Poon MA, O'Connell MJ, Moertel CG et al: Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7: 1407-1418, 1989.
5. Borner MM, Castiglione M, Bacchi M et al: The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Ann Oncol 9: 535-541, 1998.
6. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group: Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10: 904-911, 1992.
7. Scheithauer W, Rosen H, Kornek GV et al: Randomized comparison of combination chemotherapy plus supportive care or supportive care alone in patients with metastatic colorectal cancer. BMJ 306: 752-755, 1993.
8. Aranda E, Diaz-Rubio E, Cervantes A et al: Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study. Ann Oncol 9: 727-731, 1998.
9. Buirge RE: Carcinoma of the large intestine. Arch Surg 42: 801-818, 1941.
10. Cedermark BJ, Blumenson LE, Pickren JW et al: The significance of metastases to the adrenal glands in adenocarcinoma of the colon and rectum. Surg Gynecol Obstet 144: 537-546, 1977.
11. Weiss L, Grundmann E, Torhorst J et al: Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150: 195-203, 1986.
12. Ambiru S, Miyazaki M, Isono T et al: Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 42: 632-639, 1999.
13. Kemeny N and Fata F: Hepatic-arterial chemotherapy. Lancet Oncol 2: 418-428, 2001.
14. Scheele J, Stang R, Altendorf-Hofmann A et al: Resection of colorectal liver metastases. World J Surg 19: 59-71, 1995.
15. Rodgers MS and McCall JL: Surgery for colorectal liver metastases with hepatic lymph node involvement: a systemic review. Br J Surg 87: 1142-1155, 2000.
16. Kemeny N, Daly J, Reichman B et al: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107: 459-465, 1987.
17. Chang AE, Schneider PD, Sugarbaker PH et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206: 685-693, 1987.
18. Kemeny MM, Goldberg D, Beatty JD et al: Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57: 492-498, 1986.
19. Hohn DC, Stagg RJ, Friedman MA et al: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 7: 1646-1654, 1989.
20. Martin JK, O'Connel MJ, Wieand HS et al: Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 125: 1022-1027, 1990.
21. Rougier P, Laplanche A, Huguier M et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10: 1112-1118, 1992.
22. Allen-Mersh TG, Earlam S, Fordy C et al: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255-1260, 1994.
23. Lorenz M: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intra-venous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18: 243-254, 2000.
24. Poon MA, O'connell MJ, Wieand HS et al: Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9: 1967-1972, 1991.
25. Buroker TR, O'connell MJ, Wieand HS et al: Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12: 14-20, 1994.
26. Adler S, Lang S and Langenmayer I: Chronotherapy with 5-Fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trial. Cancer 73: 2905-2912, 1994.
27. Andersen LJ, Brunsgaard NH, Mejlholm I et al: Metastatic or locally advanced colorectal cancer treated with 5-Fluorouracil and low dose leucovorin. Acta Oncologica 33: 931-934, 1994.
28. Leichman CG, Fleming TR, Muggia FM et al: Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol 13: 1303-1311, 1995.
29. Labianca R, Cascinu S, Frontini L et al: High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Ann Oncol 8: 169-174, 1997.
30. Maroun JA, Cripps C, Goel R et al: Retrospective comparative analysis of 5FU+low-dose folinic acid vs. 5FU+high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience. Ann J Clin Oncol 20: 387-392, 1997.
31. de Gramont A, Bosset JF, Milan C et al: Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French Intergroup Study. J Clin Oncol 15: 808-815, 1997.
32. Ychou M, Fabbro-Peray P, Perney P et al: A prospective randomized study comparing high- and low-dose leucovorin combined with same-dose 5-fluorouracil in advanced colorectal cancer. Am J Clin Oncol 21: 233-236, 1998.
33. Tomiak A, Vincent M, Kocha W et al: Standard dose (Mayo regimen) 5-fluorouracil and low dose folinic acid: prohibitive toxicity? Am J Clin Oncol 23: 94-98, 2000.
34. Watkins E Jr, Khazei AM and Nahra KS: Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 130: 581-605, 1970.
35. Curley SA, Hohn DC and Roh MS: Hepatic artery infusion pumps: cannulation techniques and other surgical considerations. Langenbecks Arch Chir 375: 119-124, 1990.
36. Takeuchi Y, Arai Y, Inaba Y et al: A new percutaneous catheterization 'side holed catheter placement with fixation' for a long term arterial chemotherapeutic infusion: its effectiveness to prevent hepatic arterial occlusion. Jpn J Intervent Cardiol 11: 471-476, 1996.
37. Smith DB, Newlands ES, Rustin GJS et al: Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338: 487-490, 1991.
38. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset publication no. 48, Geneva, 1979.
39. Yoshimatsu K, Kato H, Ishibashi K et al: Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy. Cancer Chemother Pharmacol 52: 465-468, 2003.
40. The Meta-analysis Group in Cancer: Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301-308, 1998.
41. Takahashi Y and Nishioka K: Survival without tumor shrinkage: re-evaluation of survival gain by cytostatic effect of chemotherapy. J Natl Cancer Inst 87: 1262-1263, 1995.
42. Meta-Analysis Group In Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88: 252-258, 1996.
43. Tanaka T, Arai Y, Inaba Y et al: Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 14: 63-68, 2003.
44. Douillard JY, Cunningham D, Roth AD et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 355: 1041-1047, 2000.
45. Goldberg RM, Sargent DJ, Morton RF et al: A Randomized controlled trial of fluorouracil plus leucovorin, Irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30, 2004.